Search by Drug Name or NDC

    NDC 00469-0647-73 ASTAGRAF XL 0.5 mg/1 Details

    ASTAGRAF XL 0.5 mg/1

    ASTAGRAF XL is a ORAL CAPSULE, COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Astellas Pharma US, Inc.. The primary component is TACROLIMUS.

    Product Information

    NDC 00469-0647
    Product ID 0469-0647_15be9383-263f-4080-bda4-2ab0bdfbf239
    Associated GPIs 99404080007005
    GCN Sequence Number 062896
    GCN Sequence Number Description tacrolimus CAP ER 24H 0.5 MG ORAL
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 98662
    HICL Sequence Number 020974
    HICL Sequence Number Description TACROLIMUS
    Brand/Generic Brand
    Proprietary Name ASTAGRAF XL
    Proprietary Name Suffix n/a
    Non-Proprietary Name tacrolimus extended-release capsules
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/1
    Substance Name TACROLIMUS
    Labeler Name Astellas Pharma US, Inc.
    Pharmaceutical Class Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA204096
    Listing Certified Through 2024-12-31

    Package

    NDC 00469-0647-73 (00469064773)

    NDC Package Code 0469-0647-73
    Billing NDC 00469064773
    Package 1 BOTTLE in 1 CARTON (0469-0647-73) / 30 CAPSULE, COATED, EXTENDED RELEASE in 1 BOTTLE
    Marketing Start Date 2013-07-19
    NDC Exclude Flag N
    Pricing Information N/A